✦ LIBER ✦

The PREDICTIVETMStudy: a multinational, prospective observational study to evaluate the safety and efficacy of insulin detemir treatment in patients with type 1 and 2 diabetes—data from the Japan cohort

✍ Scribed by Mitsuyoshi Namba; Kohei Kaku; Narihito Yoshioka; Yuichiro Yamada; Hirotaka Watada; Kohjiro Ueki; Yasuo Terauchi; Kazuyuki Tobe; Eiichi Araki; Yujin Shuto; Takashi Kadowaki

Book ID: 113110514
Publisher: Springer Japan
Year: 2011
Tongue: English
Weight: 439 KB
Volume: 3
Category: Article
ISSN: 2190-1678
DOI: 10.1007/s13340-011-0051-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PREDICTIVE™– a global, prospective obser

PREDICTIVE™– a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort

✍ H.-J. Lüddeke; S. Sreenan; S. Aczel; S. Maxeiner; M. Yenigun; P. Kozlovski; H. G 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Safety and efficacy of insulin detemir i

Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVETM European cohort

✍ A. Dornhorst; H-J Lüddeke; S. Sreenan; C. Koenen; J. B. Hansen; A. Tsur; L. Land 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB

Switching from NPH insulin to once-daily

Switching from NPH insulin to once-daily insulin detemir in basal–bolus-treated patients with diabetes mellitus: data from the European cohort of the PREDICTIVE™ study

✍ S. Sreenan; A. Virkamäki; K. Zhang; J. B. Hansen; on behalf of the PREDICTIVE™ s 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Insulin detemir improves glycaemic contr

Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE™ study in a cohort of French patients with type 1 or type 2 diabetes

✍ M. Marre; M. Pinget; H. Gin; C. Thivolet; H. Hanaire; J.-J. Robert; P. Fontaine 📂 Article 📅 2009 🏛 Masson Editeur 🌐 French ⚖ 307 KB

The safety and efficacy of adding once-d

The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

✍ K. Khunti; S. Caputo; T. Damci; G. J. Dzida; Q. Ji; M. Kaiser; E. Karnieli; A. L 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 604 KB

A multicentre, multinational, randomized

A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetes

✍ Yang, S. J.; Min, K. W.; Gupta, S. K.; Park, J. Y.; Shivane, V. K.; Pitale, S. U 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 600 KB